{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T22:26:17Z","timestamp":1791584777796,"version":"4.3.4"},"reference-count":133,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropeptides"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.npep.2025.102559","type":"journal-article","created":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T16:59:10Z","timestamp":1757091550000},"page":"102559","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Therapeutic potential of small peptides in Alzheimer's disease: Advances in memory restoration and targeted delivery systems"],"prefix":"10.1016","volume":"114","author":[{"given":"Poonam","family":"Verma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rubina","family":"Khatun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiran Anjum","family":"Jew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shakti Ketan","family":"Prusty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shira","family":"Knafo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.npep.2025.102559_bb0005","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.3390\/ph15101283","article-title":"Strategies for improving peptide stability and delivery","volume":"15","author":"Al Musaimi","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.npep.2025.102559_bb0010","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.3390\/pharmaceutics14091870","article-title":"Nose-to-brain delivery of therapeutic peptides as nasal aerosols","volume":"14","author":"Alabsi","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.npep.2025.102559_bb0015","article-title":"Intranasal drug delivery: pathways, challenges, and advancements in CNS targeting","volume":"107","author":"Al-Hajaj","year":"2025","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.npep.2025.102559_bb0020","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.addr.2012.09.037","article-title":"Liposomal drug delivery systems: from concept to clinical applications","volume":"65","author":"Allen","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.npep.2025.102559_bb0025","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1177\/1073858416670124","article-title":"Neurons versus networks: the interplay between individual neurons and neural networks in cognitive functions","volume":"23","author":"Arshavsky","year":"2017","journal-title":"Neuroscientist"},{"key":"10.1016\/j.npep.2025.102559_bb0030","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.neuroscience.2017.10.002","article-title":"Peptides acting as cognitive enhancers","volume":"370","author":"Asua","year":"2018","journal-title":"Neuroscience"},{"key":"10.1016\/j.npep.2025.102559_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.npep.2025.102505","article-title":"Mechanistic role of proteins and peptides in Management of Neurodegenerative Disorders","volume":"110","author":"Awasthi","year":"2025","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2025.102559_bb0040","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/nrn2194","article-title":"Tau-mediated neurodegeneration in Alzheimer\u2019s disease and related disorders","volume":"8","author":"Ballatore","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.npep.2025.102559_bb0045","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cbpa.2019.04.019","article-title":"Tag and release: strategies for the intracellular cleavage of protein conjugates","volume":"52","author":"Baumann","year":"2019","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.npep.2025.102559_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116910","article-title":"Covalent conjugation and non-covalent complexation strategies for intracellular delivery of proteins using cell-penetrating peptides","volume":"176","author":"Behzadipour","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.npep.2025.102559_bb0055","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41467-023-44301-z","article-title":"Non-canonical interplay between glutamatergic NMDA and dopamine receptors shapes synaptogenesis","volume":"15","author":"B\u00e9nac","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.npep.2025.102559_bb0060","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0896-6273(93)90279-Z","article-title":"Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: distinction between PHF-like immunoreactivity and microtubule binding","volume":"11","author":"Biernat","year":"1993","journal-title":"Neuron"},{"issue":"6","key":"10.1016\/j.npep.2025.102559_bb0065","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.npep.2013.10.012","article-title":"Neuropeptides in learning and memory","volume":"47","author":"Borb\u00e9ly","year":"2013","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2025.102559_bb0070","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.3390\/cells11223629","article-title":"Intranasal peptide therapeutics: a promising avenue for overcoming the challenges of traditional CNS drug development","volume":"11","author":"Bose","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.npep.2025.102559_bb0075","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1172\/JCI118672","article-title":"A femtomolar-acting neuroprotective peptide","volume":"97","author":"Brenneman","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.npep.2025.102559_bb0080","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nrd2959","article-title":"Advances in tau-focused drug discovery for Alzheimer\u2019s disease and related tauopathies","volume":"8","author":"Brunden","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.npep.2025.102559_bb0085","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.npep.2017.11.010","article-title":"Peptides isolated from animal venom as a platform for new therapeutics for the treatment of Alzheimer\u2019s disease","volume":"67","author":"Camargo","year":"2018","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2025.102559_bb0090","doi-asserted-by":"crossref","first-page":"4197","DOI":"10.1523\/JNEUROSCI.0436-04.2004","article-title":"A synthetic neural cell adhesion molecule mimetic peptide promotes synaptogenesis, enhances pre-synaptic function, and facilitates memory consolidation","volume":"24","author":"Cambon","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.npep.2025.102559_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.crphar.2023.100153","article-title":"The therapeutic potential of carnosine: focus on cellular and molecular mechanisms","volume":"4","author":"Caruso","year":"2023","journal-title":"Curr Res Pharmacol Drug Discov"},{"key":"10.1016\/j.npep.2025.102559_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2024.148987","article-title":"The microtubule-dynamin binding inhibitor peptide PHDP5 rescues spatial learning and memory deficits in Alzheimer\u2019s disease model mice","volume":"1838","author":"Chang","year":"2024","journal-title":"Brain Res."},{"key":"10.1016\/j.npep.2025.102559_bb0105","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.7150\/thno.61747","article-title":"Oral delivery of protein and peptide drugs: from non-specific formulation approaches to intestinal cell targeting strategies","volume":"12","author":"Chen","year":"2022","journal-title":"Theranostics"},{"issue":"7","key":"10.1016\/j.npep.2025.102559_bb0110","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41582-018-0013-z","article-title":"Tau-targeting therapies for Alzheimer disease","volume":"14","author":"Congdon","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.npep.2025.102559_bb0115","doi-asserted-by":"crossref","first-page":"705","DOI":"10.4103\/1673-5374.322423","article-title":"Microglia regulation of synaptic plasticity and learning and memory","volume":"17","author":"Cornell","year":"2022","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.npep.2025.102559_bb0120","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1001\/jamaneurol.2020.1840","article-title":"Safety, efficacy, and feasibility of intranasal insulin for the treatment of mild cognitive impairment and Alzheimer disease dementia: a randomized clinical trial","volume":"77","author":"Craft","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.npep.2025.102559_bb0125","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1101\/lm.2154311","article-title":"The neural cell adhesion molecule-derived peptide FGL facilitates long-term plasticity in the dentate gyrus in vivo","volume":"18","author":"Dall\u00e9rac","year":"2011","journal-title":"Learn. Mem."},{"key":"10.1016\/j.npep.2025.102559_bb0130","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.biopha.2018.09.097","article-title":"Cell penetrating peptides: a concise review with emphasis on biomedical applications","volume":"108","author":"Derakhshankhah","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.npep.2025.102559_bb0135","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/jps.21924","article-title":"Intranasal delivery to the central nervous system: mechanisms and experimental considerations","volume":"99","author":"Dhuria","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.npep.2025.102559_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.npep.2024.102457","article-title":"Research progress on the protection and mechanism of active peptides in Alzheimer\u2019s disease and Parkinson\u2019s disease","volume":"107","author":"Ding","year":"2024","journal-title":"Neuropeptides"},{"issue":"27","key":"10.1016\/j.npep.2025.102559_bb0145","doi-asserted-by":"crossref","first-page":"28531","DOI":"10.1074\/jbc.M403197200","article-title":"A femtomolar acting octapeptide interacts with tubulin and protects astrocytes against zinc intoxication","volume":"279","author":"Divinski","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.npep.2025.102559_bb0150","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1006\/mcne.1996.0049","article-title":"CAM-FGF receptor interactions: a model for axonal growth","volume":"8","author":"Doherty","year":"1996","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.npep.2025.102559_bb0155","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.4155\/fmc-2020-0140","article-title":"The world of cell penetrating: the future of medical applications","volume":"12","author":"Falanga","year":"2020","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.npep.2025.102559_bb0165","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s13063-019-3259-x","article-title":"Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer\u2019s disease: study protocol for a randomised controlled trial (ELAD study)","volume":"20","author":"Femminella","year":"2019","journal-title":"Trials"},{"key":"10.1016\/j.npep.2025.102559_bb0170","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s13195-018-0427-2","article-title":"Adaptive crossover designs for assessment of symptomatic treatments targeting behaviour in neurodegenerative disease: a phase 2 clinical trial of intranasal oxytocin for frontotemporal dementia (FOXY)","volume":"10","author":"Finger","year":"2018","journal-title":"Alzheimer\u2019s Res Ther"},{"key":"10.1016\/j.npep.2025.102559_bb0175","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.molmed.2017.06.003","article-title":"Amylin receptor: a potential therapeutic target for Alzheimer\u2019s disease","volume":"23","author":"Fu","year":"2017","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.npep.2025.102559_bb0180","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.3390\/cells12182251","article-title":"NAP (Davunetide): the neuroprotective ADNP drug candidate penetrates cell nuclei explaining pleiotropic mechanisms","volume":"12","author":"Ganaiem","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.npep.2025.102559_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114362","article-title":"Peptide-decorated nanocarriers penetrating the blood-brain barrier for imaging and therapy of brain diseases","volume":"187","author":"Gao","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.npep.2025.102559_bb0195","doi-asserted-by":"crossref","unstructured":"G\u00f6tz J, Ittner LM, F\u00e4ndrich M, Schonrock N (2008).Is Tau aggregation toxic or protective: a sensible question in the absence of sensitive methods? J Alzheimer's Dis 14:423\u2013429. doi:https:\/\/doi.org\/10.3233\/jad-2008-14410.","DOI":"10.3233\/JAD-2008-14410"},{"key":"10.1016\/j.npep.2025.102559_bib666","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1073\/pnas.93.1.427","article-title":"Neuroprotective strategy for Alzheimer disease: Intranasal administration of a fatty neuropeptide","volume":"93","author":"Gozes","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.npep.2025.102559_bb0200","first-page":"61","article-title":"A new concept in the pharmacology of neuroprotection","volume":"14","author":"Gozes","year":"2000","journal-title":"J MolNeurosci"},{"issue":"4","key":"10.1016\/j.npep.2025.102559_bib669","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1527-3458.2005.tb00053.x","article-title":"NAP: research and development of a peptide derived from activity-dependent neuroprotective protein (ADNP)","volume":"11","author":"Gozes","year":"2005","journal-title":"CNS drug reviews"},{"issue":"1","key":"10.1016\/j.npep.2025.102559_bb0205","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1385\/JMN:24:1:067","article-title":"NAP mechanisms of neuroprotection","volume":"24","author":"Gozes","year":"2004","journal-title":"J. Mol. Neurosci."},{"issue":"5","key":"10.1016\/j.npep.2025.102559_bib667","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2174\/156720507783018208","article-title":"NAP, a neuroprotective drug candidate in clinical trials, stimulates microtubule assembly in the living cell","volume":"4","author":"Gozes","year":"2007","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.npep.2025.102559_bb0210","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/1471-2202-9-S3-S3","article-title":"NAP and D-SAL: neuroprotection against the \u03b2 amyloid peptide (1\u201342)","volume":"9 Suppl 3(Suppl 3)","author":"Gozes","year":"2008","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.npep.2025.102559_bb0215","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3233\/JAD-180433","article-title":"Neuroprotective effects of amylin analogues on Alzheimer\u2019s disease pathogenesis and cognition","volume":"66","author":"Grizzanti","year":"2018","journal-title":"J Alzheimer\u2019s Dis"},{"key":"10.1016\/j.npep.2025.102559_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.npep.2025.102536","article-title":"Tauopathies: emerging discoveries on tau protein, with a special focus on Alzheimer\u2019s disease","volume":"112","author":"Hattiholi","year":"2025","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2025.102559_bb0225","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.73542","article-title":"Microtubule assembly by tau impairs endocytosis and neurotransmission via dynamin sequestration in Alzheimer\u2019s disease synapse model","volume":"11","author":"Hori","year":"2022","journal-title":"eLife"},{"key":"10.1016\/j.npep.2025.102559_bb0230","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.70131","article-title":"Multi-target drug Design in Alzheimer\u2019s disease treatment: emerging technologies, advantages, challenges, and limitations","volume":"13","author":"Hossain","year":"2025","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.npep.2025.102559_bb0235","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0168-3659(02)00363-2","article-title":"Nasal drug delivery\u2014possibilities, problems and solutions","volume":"87","author":"Illum","year":"2003","journal-title":"J. Control. Release"},{"key":"10.1016\/j.npep.2025.102559_bb0240","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.1021\/acs.joc.8b03001","article-title":"Sustainability challenges in peptide synthesis and purification: from R&D to production","volume":"84","author":"Isidro-Llobet","year":"2019","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.npep.2025.102559_bb0245","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1007\/s12035-014-9053-6","article-title":"Mechanism of oxidative stress and synapse dysfunction in the pathogenesis of Alzheimer\u2019s disease: understanding the therapeutics strategies","volume":"53","author":"Kamat","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.npep.2025.102559_bb0250","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1007\/s11095-011-0440-7","article-title":"Cell-penetrating peptide-modified block copolymer micelles promote direct brain delivery via intranasal administration","volume":"28","author":"Kanazawa","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.npep.2025.102559_bb0255","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.drudis.2013.05.011","article-title":"Future directions for peptide therapeutics development","volume":"18","author":"Kaspar","year":"2013","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.npep.2025.102559_bb0260","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jconrel.2017.09.001","article-title":"Progress in brain targeting drug delivery system by nasal route","volume":"268","author":"Khan","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.npep.2025.102559_bb0265","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0969-2126(03)00096-0","article-title":"Structural basis for a direct interaction between FGFR1 and NCAM and evidence for a regulatory role of ATP","volume":"11","author":"Kiselyov","year":"2003","journal-title":"Structure"},{"key":"10.1016\/j.npep.2025.102559_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.npep.2024.102415","article-title":"A recent update on drugs and alternative approaches for parkinsonism","volume":"104","author":"Kispotta","year":"2024","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2025.102559_bb0275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1001262","article-title":"Facilitation of AMPA receptor synaptic delivery as a molecular mechanism for cognitive enhancement","volume":"10","author":"Knafo","year":"2012","journal-title":"PLoS Biol."},{"key":"10.1016\/j.npep.2025.102559_bb0280","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nn.4225","article-title":"PTEN recruitment controls synaptic and cognitive function in Alzheimer\u2019s models","volume":"19","author":"Knafo","year":"2016","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.npep.2025.102559_bb0285","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1021\/bc5005763","article-title":"Conjugation of cell-penetrating peptides to parathyroid hormone affects its structure, potency, and Transepithelial permeation","volume":"26","author":"Kristensen","year":"2015","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.npep.2025.102559_bb0290","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/cne.24577","article-title":"Distribution of endogenous normal tau in the mouse brain","volume":"527","author":"Kubo","year":"2019","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.npep.2025.102559_bb0295","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jconrel.2022.03.017","article-title":"Nose-to-brain\/spinal cord delivery kinetics of liposomes with different surface properties","volume":"344","author":"Kurano","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.npep.2025.102559_bb0300","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13195-018-0340-8","article-title":"Safety, tolerability and immunogenicity of an active anti-A\u03b240 vaccine (ABvac40) in patients with Alzheimer\u2019s disease: a randomised, double-blind, placebo-controlled, phase I trial","volume":"10","author":"Lacosta","year":"2018","journal-title":"Alzheimer\u2019s Res Ther"},{"key":"10.1016\/j.npep.2025.102559_bb0305","first-page":"39","article-title":"Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice","volume":"6","author":"Lasagna-Reeves","year":"2011","journal-title":"MolNeurodegeneration"},{"issue":"December","key":"10.1016\/j.npep.2025.102559_bb0310","article-title":"Challenges for therapeutic peptides part 2: delivery systems","volume":"43","author":"Lax","year":"2012","journal-title":"Innovat. Pharmaceut. Technol."},{"key":"10.1016\/j.npep.2025.102559_bb0315","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s11095-023-03486-0","article-title":"Strategies to improve the physicochemical properties of peptide-based drugs","volume":"40","author":"Lee","year":"2023","journal-title":"Pharm. Res."},{"key":"10.1016\/j.npep.2025.102559_bb0320","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006437","article-title":"Developing therapeutic approaches to tau, selected kinases, and related neuronal protein targets","volume":"1","author":"Lee","year":"2011","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.npep.2025.102559_bb0325","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1007\/s12035-017-0533-3","article-title":"Synaptic dysfunction in Alzheimer\u2019s disease: a\u03b2, tau, and epigenetic alterations","volume":"55","author":"Li","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.npep.2025.102559_bb0330","article-title":"Development of novel therapeutics targeting the blood-brain barrier: from barrier to carrier","volume":"8","author":"Li","year":"2021","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.npep.2025.102559_bb0335","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.addr.2011.11.002","article-title":"Intranasal delivery of biologics to the central nervous system","volume":"64","author":"Lochhead","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.npep.2025.102559_bb0340","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1471-4159.2011.07506.x","article-title":"Amyloid \u03b2: linking synaptic plasticity failure to memory disruption in Alzheimer\u2019s disease","volume":"120","author":"Ma","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.npep.2025.102559_bb0345","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.npep.2013.10.011","article-title":"Microtubule-stabilizing peptides and small molecules protecting axonal transport and brain function: focus on davunetide (NAP)","volume":"47","author":"Magen","year":"2013","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2025.102559_bb0350","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3390\/pharmaceutics11070339","article-title":"Transmucosal absorption enhancers in the drug delivery field","volume":"11","author":"Maher","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.npep.2025.102559_bb0355","doi-asserted-by":"crossref","first-page":"746","DOI":"10.3390\/pharmaceutics15030746","article-title":"Intranasal polymeric and lipid-based Nanocarriers for CNS drug delivery","volume":"15","author":"Maher","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.npep.2025.102559_bb0360","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1124\/jpet.107.130526","article-title":"A neuronal microtubule-interacting agent, NAPVSIPQ, reduces tau pathology and enhances cognitive function in a mouse model of Alzheimer\u2019s disease","volume":"325","author":"Matsuoka","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.npep.2025.102559_bb0365","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.npep.2017.05.001","article-title":"Neuropeptides: a promising target for treating seizures","volume":"65","author":"Menon","year":"2017","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2025.102559_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.npep.2025.102515","article-title":"Bioactive peptides as multipotent molecules bespoke and designed for Alzheimer's disease","volume":"111","author":"Mesias","year":"2025","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2025.102559_bb0375","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1152\/jn.1998.79.1.496","article-title":"Acute Intrahippocampal infusion of BDNF induces lasting potentiation of synaptic transmission in the rat dentate gyrus","volume":"79","author":"Messaoudi","year":"1998","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.npep.2025.102559_bb0380","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.neuropharm.2017.12.016","article-title":"Amylin in Alzheimer\u2019s disease: pathological peptide or potential treatment?","volume":"136","author":"Mietlicki-Baase","year":"2018","journal-title":"Neuropharmacology"},{"issue":"15","key":"10.1016\/j.npep.2025.102559_bb0385","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1080\/00914037.2024.2443165","article-title":"Optimizing nasal drug delivery for peptides, proteins, and small molecules: strategic use of materials and techniques to target the CNS","volume":"74","author":"Mittal","year":"2024","journal-title":"Int. J. Polym. Mater. Polym. Biomater."},{"key":"10.1016\/j.npep.2025.102559_bb0390","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.3233\/JAD-160800","article-title":"Amylin enhances amyloid-\u03b2 peptide brain to blood efflux across the blood-brain barrier","volume":"56","author":"Mohamed","year":"2017","journal-title":"JAD"},{"key":"10.1016\/j.npep.2025.102559_bb0395","doi-asserted-by":"crossref","first-page":"494","DOI":"10.3389\/fnins.2020.00494","article-title":"Nanotechnology: a promising approach for delivery of neuroprotective drugs","volume":"14","author":"Naqvi","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.npep.2025.102559_bb0400","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/j.1471-4159.2004.02779.x","article-title":"An NCAM-derived FGF-receptor agonist, the FGL-peptide, induces neurite outgrowth and neuronal survival in primary rat neurons","volume":"91","author":"Neiiendam","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.npep.2025.102559_bb0405","doi-asserted-by":"crossref","first-page":"63","DOI":"10.14283\/jpad.2018.45","article-title":"AADvac1, an active immunotherapy for Alzheimer\u2019s disease and non Alzheimer Tauopathies: an overview of preclinical and clinical development","volume":"6","author":"Novak","year":"2019","journal-title":"J. Prev Alzheimers Dis."},{"key":"10.1016\/j.npep.2025.102559_bb0410","doi-asserted-by":"crossref","first-page":"848","DOI":"10.3390\/molecules30040848","article-title":"The role of brain-derived neurotrophic factor as an essential mediator in neuronal functions and the therapeutic potential of its mimetics for neuroprotection in neurologic and psychiatric disorders","volume":"30","author":"Numakawa","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.npep.2025.102559_bb0415","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1053\/j.sult.2022.04.001","article-title":"The olfactory nerve: anatomy and pathology","volume":"43","author":"Ottaiano","year":"2022","journal-title":"Seminars in Ultrasound, CT and MRI"},{"key":"10.1016\/j.npep.2025.102559_bb0420","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.14283\/jpad.2024.81","article-title":"Medical costs and caregiver burden of delivering disease-modifying Alzheimer\u2019s treatments with different duration and route of administration","volume":"11","author":"Ozawa","year":"2024","journal-title":"J. Prev Alzheimers Dis."},{"issue":"2","key":"10.1016\/j.npep.2025.102559_bb0425","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1471-4159.2007.04761.x","article-title":"The peptide NAP promotes neuronal growth and differentiation through extracellular signal-regulated protein kinase and Akt pathways, and protects neurons co-cultured with astrocytes damaged by ethanol","volume":"103","author":"Pascual","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.npep.2025.102559_bb0430","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1021\/acs.bioconjchem.8b00778","article-title":"Overcoming endosomal entrapment in drug delivery","volume":"30","author":"Pei","year":"2019","journal-title":"Bioconjug. Chem."},{"issue":"7","key":"10.1016\/j.npep.2025.102559_bib668","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3390\/pharmaceutics11070349","article-title":"Brain Delivery of Thyrotropin-Releasing Hormone via a Novel Prodrug Approach","volume":"11","author":"Prokai-Tatrai","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.npep.2025.102559_bb0435","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.neuroscience.2017.05.024","article-title":"Amylin and its G-protein-coupled receptor: a probable pathological process and drug target for Alzheimer\u2019s disease","volume":"356","author":"Qiu","year":"2017","journal-title":"Neuroscience"},{"key":"10.1016\/j.npep.2025.102559_bb0440","series-title":"Proteostasis","article-title":"Alzheimer\u2019s: Epidemiology, pathophysiology, diagnosis, and treatments","author":"Rahman","year":"2025"},{"key":"10.1016\/j.npep.2025.102559_bb0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102309","article-title":"Mechanistic insights and emerging therapeutic stratagems for Alzheimer\u2019s disease","volume":"97","author":"Rajendran","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.npep.2025.102559_bb0450","article-title":"Phosphorylated tau in Alzheimer\u2019s disease and other Tauopathies","volume":"23","author":"Rawat","year":"2022","journal-title":"IJMS"},{"key":"10.1016\/j.npep.2025.102559_bb0455","article-title":"Therapeutic proteins immunogenicity: a peptide point of view","volume":"377\u2013387","author":"Real-Fernandez","year":"2023","journal-title":"Explor Drug Sci"},{"key":"10.1016\/j.npep.2025.102559_bb0460","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3390\/molecules23020283","article-title":"Peptides as potential therapeutics for Alzheimer\u2019s disease","volume":"23","author":"Ribari\u010d","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.npep.2025.102559_bb0470","series-title":"ADME Processes in Pharmaceutical Sciences","article-title":"Routes of drug administration: Dosage, design, and pharmacotherapy success","author":"Ruiz","year":"2018"},{"key":"10.1016\/j.npep.2025.102559_bb0475","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0955-0674(97)80115-9","article-title":"Neural recognition molecules and synaptic plasticity","volume":"9","author":"Schachner","year":"1997","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.npep.2025.102559_bb0480","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.neuroscience.2006.04.059","article-title":"A neural cell adhesion molecule\u2013derived fibroblast growth factor receptor agonist, the FGL-peptide, promotes early postnatal sensorimotor development and enhances social memory retention","volume":"141","author":"Secher","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.npep.2025.102559_bb0485","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.bbr.2008.12.012","article-title":"Effect of an NCAM mimetic peptide FGL on impairment in spatial learning and memory after neonatal phencyclidine treatment in rats","volume":"199","author":"Secher","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.npep.2025.102559_bb0495","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114904","article-title":"Strategies for overcoming protein and peptide instability in biodegradable drug delivery systems","volume":"199","author":"Shi","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.npep.2025.102559_bb0500","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/355733a0","article-title":"Dynamin is a GTPase stimulated to high levels of activity by microtubules","volume":"355","author":"Shpetner","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.npep.2025.102559_bb0505","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3390\/brainsci15030252","article-title":"Phytochemicals targeting BDNF Signalling for treating neurological disorders","volume":"15","author":"Singh","year":"2025","journal-title":"Brain Sci."},{"key":"10.1016\/j.npep.2025.102559_bb0510","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.trci.2016.11.005","article-title":"Cyclic AC253, a novel amylin receptor antagonist, improves cognitive deficits in a mouse model of Alzheimer\u2019s disease","volume":"3","author":"Soudy","year":"2017","journal-title":"A&D Transl Res & Clin Interv"},{"key":"10.1016\/j.npep.2025.102559_bb0515","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1474-4422(13)70090-5","article-title":"Tau pathology and neurodegeneration","volume":"12","author":"Spillantini","year":"2013","journal-title":"Lancet Neurol."},{"issue":"19","key":"10.1016\/j.npep.2025.102559_bb0520","first-page":"4597","article-title":"A current review on transdermal delivery of protein and peptides: possibilities and challenges","volume":"21","author":"Thakur","year":"2025","journal-title":"LDDD"},{"key":"10.1016\/j.npep.2025.102559_bb0525","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.neuroscience.2004.05.029","article-title":"Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration","volume":"127","author":"Thorne","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.npep.2025.102559_bb0530","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.2174\/0929867321666140217125857","article-title":"Peptide Therapeutics in Neurodegenerative Disorders","volume":"21","author":"Tiwari","year":"2014","journal-title":"CMC"},{"key":"10.1016\/j.npep.2025.102559_bb0535","doi-asserted-by":"crossref","first-page":"470","DOI":"10.3390\/pr9030470","article-title":"Drug carriers: classification, administration, release profiles, and industrial approach","volume":"9","author":"Trucillo","year":"2021","journal-title":"Processes"},{"key":"10.1016\/j.npep.2025.102559_bb0540","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41582-022-00749-z","article-title":"Synaptic degeneration in Alzheimer disease","volume":"19","author":"Tzioras","year":"2023","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.npep.2025.102559_bb0545","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.trci.2018.06.012","article-title":"Intranasal rifampicin for Alzheimer\u2019s disease prevention","volume":"4","author":"Umeda","year":"2018","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.1016\/j.npep.2025.102559_bb0550","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.trci.2016.12.003","article-title":"Active a\u03b2 immunotherapy CAD106 in Alzheimer\u2019s disease: a phase 2b study","volume":"3","author":"Vandenberghe","year":"2017","journal-title":"Alzheimers Dement (NY)"},{"issue":"1","key":"10.1016\/j.npep.2025.102559_bb0555","first-page":"67","article-title":"Transdermal drug delivery systems: a focused review of the physical methods of permeation enhancement","volume":"14","author":"Vaseem","year":"2023","journal-title":"Adv Pharm Bull."},{"key":"10.1016\/j.npep.2025.102559_bb0560","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/ddr.21832","article-title":"Challenges of peptide and protein drug delivery by oral route: current strategies to improve the bioavailability","volume":"82","author":"Verma","year":"2021","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.npep.2025.102559_bb0565","series-title":"Peptide Therapeutics. AAPS Advances in the Pharmaceutical Sciences Series","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-031-04544-8_5","article-title":"Therapeutic peptide delivery: Fundamentals, formulations, and recent advances","volume":"vol. 47","author":"Vora","year":"2022"},{"key":"10.1016\/j.npep.2025.102559_bb0570","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcac022","article-title":"An amyloid beta vaccine that safely drives immunity to a key pathological species in Alzheimer\u2019s disease: pyroglutamate amyloid beta","volume":"4","author":"Vukicevic","year":"2022","journal-title":"Brain Commun"},{"key":"10.1016\/j.npep.2025.102559_bb0575","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1124\/jpet.107.129551","article-title":"Activity-dependent neuroprotective protein snippet NAP reduces tau hyperphosphorylation and enhances learning in a novel transgenic mouse model","volume":"323","author":"Vulih-Shultzman","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.npep.2025.102559_bb0580","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1007\/s12035-015-9143-0","article-title":"The essential role of soluble a\u03b2 oligomers in Alzheimer\u2019s disease","volume":"53","author":"Wang","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.npep.2025.102559_bb0585","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3233\/JAD-160677","article-title":"Amylin treatment reduces Neuroinflammation and ameliorates abnormal patterns of gene expression in the cerebral cortex of an Alzheimer\u2019s disease mouse model","volume":"56","author":"Wang","year":"2017","journal-title":"J Alzheimer\u2019s Dis"},{"key":"10.1016\/j.npep.2025.102559_bb0590","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2023.106623","article-title":"The prescription design and key properties of nasal gel for CNS drug delivery: a review","volume":"192","author":"Wang","year":"2024","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.npep.2025.102559_bb0595","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2174\/187152710793361595","article-title":"Therapeutic potential of vasoactive intestinal peptide and its receptors in neurological disorders","volume":"9","author":"White","year":"2010","journal-title":"CNSNDDT"},{"key":"10.1016\/j.npep.2025.102559_bb0600","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232415811","article-title":"Current insights on the use of insulin and the potential use of insulin mimetics in targeting insulin Signalling in Alzheimer\u2019s disease","volume":"23","author":"Woodfield","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.npep.2025.102559_bb0605","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3389\/fphar.2020.00697","article-title":"Cell-penetrating peptides in diagnosis and treatment of human diseases: from preclinical research to clinical application","volume":"11","author":"Xie","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.npep.2025.102559_bb0610","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2020.626882","article-title":"Design and application in delivery system of intranasal antidepressants","volume":"8","author":"Xu","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.npep.2025.102559_bb0615","doi-asserted-by":"crossref","first-page":"656","DOI":"10.2174\/1389203722666210920151810","article-title":"Peptide based therapy for neurological disorders","volume":"22","author":"Yadav","year":"2021","journal-title":"CPPS"},{"key":"10.1016\/j.npep.2025.102559_bb0620","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/j.1471-4159.1993.tb03642.x","article-title":"Tau in paired helical filaments is functionally distinct from fetal tau: assembly incompetence of paired helical filament-tau","volume":"61","author":"Yoshida","year":"1993","journal-title":"J. Neurochem."},{"key":"10.1016\/j.npep.2025.102559_bb0625","article-title":"Safety, tolerability, immunogenicity, and efficacy of UB-311 in participants with mild Alzheimer\u2019s disease: a randomised, double-blind, placebo-controlled, phase 2a study","volume":"94","author":"Yu","year":"2023","journal-title":"E Bio Medi."},{"key":"10.1016\/j.npep.2025.102559_bb0630","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e09030","article-title":"Study of valproic acid liposomes for delivery into the brain through an intranasal route","volume":"8","author":"Yuwanda","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.npep.2025.102559_bb0635","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0167-0115(00)00198-1","article-title":"A novel peptide prevents death in enriched neuronal cultures","volume":"96","author":"Zemlyak","year":"2000","journal-title":"Regul. Pept."},{"key":"10.1016\/j.npep.2025.102559_bb0640","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1111\/j.1471-4159.2009.06415.x","article-title":"The microtubule interacting drug candidate NAP protects against kainic acid toxicity in a rat model of epilepsy","volume":"111","author":"Zemlyak","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.npep.2025.102559_bb0645","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.3390\/pharmaceutics15082093","article-title":"Recent advances of cell-penetrating peptides and their application as vectors for delivery of peptide and protein-based cargo molecules","volume":"15","author":"Zhang","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.npep.2025.102559_bb0650","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.neuroscience.2019.05.033","article-title":"Insulin modulates excitatory synaptic transmission and synaptic plasticity in the mouse Hippocampus","volume":"411","author":"Zhao","year":"2019","journal-title":"Neuroscience"},{"key":"10.1016\/j.npep.2025.102559_bb0655","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/mp.2014.17","article-title":"Intraperitoneal injection of the pancreatic peptide amylin potently reduces behavioral impairment and brain amyloid pathology in murine models of Alzheimer\u2019s disease","volume":"20","author":"Zhu","year":"2015","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.npep.2025.102559_bb0660","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.trci.2016.12.002","article-title":"An amylin analog used as a challenge test for Alzheimer\u2019s disease","volume":"3","author":"Zhu","year":"2017","journal-title":"Alzheimers Dement (NY)"},{"key":"10.1016\/j.npep.2025.102559_bb0665","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.neuropharm.2017.03.030","article-title":"Amylin receptor ligands reduce the pathological cascade of Alzheimer\u2019s disease","volume":"119","author":"Zhu","year":"2017","journal-title":"Neuropharmacology"}],"container-title":["Neuropeptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143417925000599?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143417925000599?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T04:36:54Z","timestamp":1780634214000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143417925000599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":133,"alternative-id":["S0143417925000599"],"URL":"https:\/\/doi.org\/10.1016\/j.npep.2025.102559","relation":{},"ISSN":["0143-4179"],"issn-type":[{"value":"0143-4179","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic potential of small peptides in Alzheimer's disease: Advances in memory restoration and targeted delivery systems","name":"articletitle","label":"Article Title"},{"value":"Neuropeptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.npep.2025.102559","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102559"}}